{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:34:51Z","timestamp":1789684491485,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.det.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T06:30:58Z","timestamp":1347949858000},"page":"67-73","source":"Crossref","is-referenced-by-count":54,"title":["Drugs and Hair Loss"],"prefix":"10.1016","volume":"31","author":[{"given":"Mansi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2230.2002.01080.x","article-title":"Telogen effluvium","volume":"27","author":"Harrison","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/jid.1959.156","article-title":"The human hair cycle","volume":"33","author":"Kligman","year":"1959","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.002_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0733-8635(05)70398-3","article-title":"Chronic telogen effluvium","volume":"14","author":"Whiting","year":"1996","journal-title":"Dermatol Clin"},{"issue":"7","key":"10.1016\/j.det.2012.08.002_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","volume":"341","author":"Paus","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.det.2012.08.002_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3949\/ccjm.76a.08080","article-title":"Diffuse hair loss: its triggers and management","volume":"76","author":"Harrison","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.det.2012.08.002_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CCID.S10182","article-title":"Alopecia: evaluation and treatment","volume":"4","author":"Gordon","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blume-Peytavi","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.08.002_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-4362.1995.tb01556.x","article-title":"Drug-associated alopecia","volume":"34","author":"Pillans","year":"1995","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10401230009147085","article-title":"Hair loss in psychopharmacology","volume":"12","author":"Mercke","year":"2000","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000102031","article-title":"Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation","volume":"215","author":"Yun","year":"2007","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Trueb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000102025","article-title":"Chemotherapy-induced anagen effluvium: diffuse or patterned?","volume":"215","author":"Trueb","year":"2007","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2005.06469.x","article-title":"Permanent alopecia after busulfan chemotherapy","volume":"152","author":"Tosti","year":"2005","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000441-200105000-00005","article-title":"Cutaneous reactions to chemotherapeutic agents","volume":"321","author":"Koppel","year":"2001","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.det.2012.08.002_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0305-7372(03)00116-6","article-title":"Classification of anticancer drugs\u2013a new system based on therapeutic targets","volume":"29","author":"Espinosa","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.det.2012.08.002_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/labinvest.3700170","article-title":"Epithelium\u2013mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damage","volume":"84","author":"Selleri","year":"2004","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A\u00a0randomized trial of minoxidil in chemotherapy-induced alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.002_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.det.2007.01.005","article-title":"Drug reactions affecting hair: diagnosis","volume":"25","author":"Tosti","year":"2007","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.det.2012.08.002_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdi088","article-title":"Prevention of chemotherapy-induced hair loss by scalp cooling","volume":"16","author":"Grevelman","year":"2005","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib20","first-page":"445","article-title":"Hair loss in women","volume":"61","author":"Tosti","year":"2009","journal-title":"Minerva Ginecol"},{"issue":"3","key":"10.1016\/j.det.2012.08.002_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-0960.2010.00654.x","article-title":"Chronic telogen effluvium is due to a reduction in the variance of anagen duration","volume":"51","author":"Gilmore","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2012.08.002_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-4362.1984.tb05697.x","article-title":"Hair loss and lithium","volume":"23","author":"Mortimer","year":"1984","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.08.002_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1983.tb04607.x","article-title":"Hair loss following lithium therapy","volume":"108","author":"Orwin","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1192\/bjp.146.1.70","article-title":"The impact of lithium in South-west Scotland. I. Demographic and clinical findings","volume":"146","author":"Mccreadie","year":"1985","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1982.tb00301.x","article-title":"Hair loss during lithium treatment","volume":"107","author":"Dawber","year":"1982","journal-title":"Br J Dermatol"},{"issue":"5919","key":"10.1016\/j.det.2012.08.002_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.2.5919.584","article-title":"Sodium valproate in treatment of epilepsy","volume":"2","author":"Jeavons","year":"1974","journal-title":"Br Med J"},{"issue":"40","key":"10.1016\/j.det.2012.08.002_bib27","first-page":"1132","volume":"83","author":"Despland","year":"1994","journal-title":"Praxis (Bern 1994)"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1600-0404.1982.tb03106.x","article-title":"Clinical and pharmacokinetic observations on sodium valproate\u2014a 5-year follow-up study in 100 children with epilepsy","volume":"65","author":"Henriksen","year":"1982","journal-title":"Acta Neurol Scand"},{"issue":"6291","key":"10.1016\/j.det.2012.08.002_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.283.6291.577","article-title":"Effects of sodium valproate in 100 children with special reference to weight","volume":"283","author":"Egger","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"8884","key":"10.1016\/j.det.2012.08.002_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0140-6736(93)92782-O","article-title":"Hair loss during fluoxetine treatment","volume":"342","author":"Ogilvie","year":"1993","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.det.2012.08.002_bib31","first-page":"52","article-title":"Hair loss associated with long-term sertraline treatment in teenager","volume":"2","author":"Rais","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"issue":"2","key":"10.1016\/j.det.2012.08.002_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0033-3182(91)72085-9","article-title":"Psychotropic medication and drug-related alopecia","volume":"32","author":"Warnock","year":"1991","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2710.2006.00769.x","article-title":"Enoxaparin-induced alopecia in patients with cerebral venous thrombosis","volume":"31","author":"Wang","year":"2006","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.det.2012.08.002_bib34","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V96.4.1618","article-title":"Alopecia and dalteparin: a previously unreported association","volume":"96","author":"Barnes","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.det.2012.08.002_bib35","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood.V97.9.2914","article-title":"Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation","volume":"97","author":"Apsner","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib36","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1016\/S0272-6386(03)00211-7","article-title":"Diffuse alopecia in a hemodialysis patient caused by a low molecular- weight heparin, tinzaparin","volume":"41","author":"Sarris","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"8982","key":"10.1016\/j.det.2012.08.002_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0140-6736(95)91781-0","article-title":"Treatment of warfarin-induced hair loss with ubidecarenone","volume":"346","author":"Nagao","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib38","first-page":"63","article-title":"Warfarin-induced alopecia","volume":"42","author":"Umlas","year":"1988","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.det.2012.08.002_bib39","first-page":"633","article-title":"Metoprolol and alopecia","volume":"28","author":"Graeber","year":"1981","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib40","first-page":"63","article-title":"Propranolol and alopecia","volume":"24","author":"Hilder","year":"1979","journal-title":"Cutis"},{"issue":"9","key":"10.1016\/j.det.2012.08.002_bib41","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archderm.1977.01640090151053","article-title":"Propranolol therapy","volume":"113","author":"Scribner","year":"1977","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.08.002_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-8703(73)90250-0","article-title":"Propranolol induced alopecia","volume":"86","author":"Martin","year":"1973","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.det.2012.08.002_bib43","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1445-5994.1984.tb03797.x","article-title":"Alopecia associated with captopril treatment","volume":"14","author":"Leaker","year":"1984","journal-title":"Aust N Z J Med"},{"issue":"803","key":"10.1016\/j.det.2012.08.002_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/pgmj.68.803.771-a","article-title":"Amiodarone and hair loss","volume":"68","author":"Samuel","year":"1992","journal-title":"Postgrad Med J"},{"issue":"6386","key":"10.1016\/j.det.2012.08.002_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.287.6386.175","article-title":"Adverse reactions during treatment with amiodarone hydrochloride","volume":"287","author":"Mcgovern","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5865","key":"10.1016\/j.det.2012.08.002_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bmj.2.5865.499","article-title":"Hair loss and contraceptives","volume":"2","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.det.2012.08.002_bib47","author":"Se","year":"2007"},{"issue":"3","key":"10.1016\/j.det.2012.08.002_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-0960.2009.00542.x","article-title":"Repigmentation and curling of hair after acitretin therapy","volume":"50","author":"Seckin","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0970-2113.76304","article-title":"Isoniazid-induced alopecia","volume":"28","author":"Gupta","year":"2011","journal-title":"Lung India"},{"issue":"8999","key":"10.1016\/j.det.2012.08.002_bib50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(96)90048-3","article-title":"Alopecia side effect of antituberculosis drugs","volume":"347","author":"Fitzgerald","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.det.2012.08.002_bib51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/0956462001916146","article-title":"Indinavir use: associated reversible hair loss and mood disturbance","volume":"11","author":"Harry","year":"2000","journal-title":"Int J STD AIDS"},{"issue":"12","key":"10.1016\/j.det.2012.08.002_bib52","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/00002030-200208160-00021","article-title":"Generalized hair loss induced by indinavir plus ritonavir therapy","volume":"16","author":"Ginarte","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.det.2012.08.002_bib53","series-title":"Product information leaflet","author":"Mirena","year":"2009"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib54","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2008.08529.x","article-title":"Onset of lichen planopilaris during treatment with etanercept","volume":"158","author":"Garcovich","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2012.08.002_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00847.x","article-title":"Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis","volume":"26","author":"Abbasi","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1346-8138.2001.tb00012.x","article-title":"Childhood lichen planopilaris: a study of 87 cases","volume":"40","author":"Handa","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib57","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1345\/aph.1P079","article-title":"Infliximab-induced lichen planopilaris","volume":"44","author":"Fernandez-Torres","year":"2010","journal-title":"Ann Pharmacol"},{"key":"10.1016\/j.det.2012.08.002_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11523-010-0162-5","article-title":"Tufted hair follicultis in a woman treated with trastuzumab","volume":"5","author":"Rosman","year":"2010","journal-title":"Target Oncol"},{"key":"10.1016\/j.det.2012.08.002_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SPC.0b013e328332d397","article-title":"Skin reactions to the new biologic anticancer drugs","volume":"3","author":"Myskowski","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.det.2012.08.002_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaad.2005.12.016","article-title":"Nonscarring alopecia associated with the epidermal growth factor receptor inhibitor gefitinib","volume":"55","author":"Graves","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2012.08.002_bib61","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.144.11.1524","article-title":"Scarring Alopecia Associated with use of the epidermal growth factor receptor inhibitor gefitinib","volume":"144","author":"Donovan","year":"2008","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.08.002_bib62","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2009.08.024","article-title":"Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib","volume":"64","author":"Hepper","year":"2011","journal-title":"J\u00a0Acad Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib63","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2230.2010.03852.x","article-title":"Folliculitis decalvans associated with erlotinib","volume":"35","author":"Hoekzema","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2012.08.002_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2230.2008.02882.x","article-title":"Tufted hair folliculitis in a woman treated with lapatinib for breast cancer","volume":"33","author":"Ena","year":"2008","journal-title":"Clin Exp Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:16:31Z","timestamp":1594682191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863512000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0733863512000903"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2012.08.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}